25635-22-7 Usage
Uses
Used in Chemical Research:
RARECHEM AL BI 0482 is used as a research compound for studying its chemical properties and potential interactions with other substances. This helps in understanding its behavior and reactivity in various chemical reactions.
Used in Pharmaceutical Development:
RARECHEM AL BI 0482 is used as a precursor or intermediate in the development of pharmaceutical drugs. Its unique structure and properties make it a valuable building block in the synthesis of new and innovative medications.
Used in Organic Synthesis:
RARECHEM AL BI 0482 is used as a key component in organic synthesis, where it can be combined with other molecules to create more complex organic compounds. This contributes to the development of new materials and chemicals with specific applications.
Used in Drug Synthesis:
RARECHEM AL BI 0482 is used as a building block in the synthesis of pharmaceutical drugs. Its unique structure allows it to be incorporated into drug molecules, potentially enhancing their efficacy, selectivity, or stability.
Check Digit Verification of cas no
The CAS Registry Mumber 25635-22-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,3 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 25635-22:
(7*2)+(6*5)+(5*6)+(4*3)+(3*5)+(2*2)+(1*2)=107
107 % 10 = 7
So 25635-22-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO2/c1-2-15-12(14)10-7-3-5-9-6-4-8-13-11(9)10/h3-8H,2H2,1H3
25635-22-7Relevant academic research and scientific papers
Quinoline derivatives and medicinal use thereof
-
, (2008/06/13)
A quinoline derivative represented by the following formula (1): allows PPARα or γ which is an intranuclear transcription factor, to function strongly and is low in toxicity. By using this compound as an active ingredient, there can be provided a preventive or therapeutic agent for various diseases related to PPARα or γ.
Chiral 1,2,3,4-tetrahydroquinolinyl-oxazoline ligands for Ru-catalyzed asymmetric transfer hydrogenation of ketones
Zhou, Yi-Bo,Tang, Fang-Yi,Xu, Hua-Dong,Wu, Xin-Yan,Ma, Jun-An,Zhou, Qi-Lin
, p. 469 - 473 (2007/10/03)
Chiral 1,2,3,4-tetrahydroquinolinyl-oxazoline compounds have been synthesized from 8-quinolinecarboxylic acid and enantiomerically pure amino alcohols using a convenient procedure. Asymmetric transfer hydrogenation of aryl ketones with the catalyst prepared in situ from [Ru(p-cymene)Cl2]2 and ligands 2 in 2-propanol in the presence of KOH, afforded the corresponding secondary alcohols in reasonable yields and up to 83% e.e.
